Feed/Investors/Dexcel Pharma

Dexcel Pharma

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

Since 2025-12-18

ROUNDS

as lead investor

LED ROUNDS · USD

$82.5M

across 1 round · 1 co-led, split evenly

LATEST ROUND

Series A · $165M · 2025-12-18

CO-INVESTORS

named beside it

Rounds

[ 1 ]

The rounds this investor is named on, who it invests beside, and where it shows up.

Company	Round	Amount	Announced	Role
Syremis Therapeutics Syremis Therapeutics is a clinical-stage biopharmaceutical company developing novel medicines to make a profound impact on the treatment of mental health.	Series A Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$165M	2025-12-18	[ LEAD ]